Oppenheimer & Co »

Crinetics Pharmaceuticals In shares owned by Oppenheimer & Co

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Oppenheimer & Co from 13F filings

Historical chart of Oppenheimer & Co investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Oppenheimer & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $219k 4.7k 46.81

More positions owned by Oppenheimer & Co

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
Home Depot (HD)
Visa Com Cl A (V)

View all positions for Oppenheimer & Co

Top funds holding Crinetics Pharmaceuticals In

BlackRock
Point72 Asset Management
FMR
EcoR1 Capital
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Paradigm Biocapital Advisors
Jennison Associates
T. Rowe Price Investment Management
Henderson Group
First Light Asset Management
Perceptive Advisors
Geode Capital Management
Artal Group

View all funds holding Crinetics Pharmaceuticals In